BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30092832)

  • 1. High mammographic density in women is associated with protumor inflammation.
    Huo CW; Hill P; Chew G; Neeson PJ; Halse H; Williams ED; Henderson MA; Thompson EW; Britt KL
    Breast Cancer Res; 2018 Aug; 20(1):92. PubMed ID: 30092832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.
    Huo CW; Chew G; Hill P; Huang D; Ingman W; Hodson L; Brown KA; Magenau A; Allam AH; McGhee E; Timpson P; Henderson MA; Thompson EW; Britt K
    Breast Cancer Res; 2015 Jun; 17(1):79. PubMed ID: 26040322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis.
    Huo CW; Waltham M; Khoo C; Fox SB; Hill P; Chen S; Chew GL; Price JT; Nguyen CH; Williams ED; Henderson M; Thompson EW; Britt KL
    Breast Cancer Res; 2016 Oct; 18(1):106. PubMed ID: 27776557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of breast tissue density: Correlation between single-sided portable NMR and micro-CT measurements.
    Huang X; Ali TS; Nano T; Blick T; Tse BW; Sokolowski K; Tourell MC; Lloyd T; Thompson EW; Momot KI; Hugo HJ
    Magn Reson Imaging; 2019 Oct; 62():111-120. PubMed ID: 31176808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    Wen WX; Leong CO
    PLoS One; 2019; 14(4):e0215381. PubMed ID: 31022191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transverse relaxation-based assessment of mammographic density and breast tissue composition by single-sided portable NMR.
    Ali TS; Tourell MC; Hugo HJ; Pyke C; Yang S; Lloyd T; Thompson EW; Momot KI
    Magn Reson Med; 2019 Sep; 82(3):1199-1213. PubMed ID: 31034648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.
    Degnim AC; Hoskin TL; Arshad M; Frost MH; Winham SJ; Brahmbhatt RA; Pena A; Carter JM; Stallings-Mann ML; Murphy LM; Miller EE; Denison LA; Vachon CM; Knutson KL; Radisky DC; Visscher DW
    Clin Cancer Res; 2017 Jul; 23(14):3945-3952. PubMed ID: 28126725
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune cell quantitation in normal breast tissue lobules with and without lobulitis.
    Degnim AC; Brahmbhatt RD; Radisky DC; Hoskin TL; Stallings-Mann M; Laudenschlager M; Mansfield A; Frost MH; Murphy L; Knutson K; Visscher DW
    Breast Cancer Res Treat; 2014 Apr; 144(3):539-49. PubMed ID: 24596048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
    Kaas R; Verhoef S; Wesseling J; Rookus MA; Oldenburg HS; Peeters MJ; Rutgers EJ
    Ann Surg; 2010 Mar; 251(3):488-92. PubMed ID: 20134318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues.
    Gabrielson M; Chiesa F; Paulsson J; Strell C; Behmer C; Rönnow K; Czene K; Östman A; Hall P
    Breast Cancer Res Treat; 2016 Jul; 158(2):253-61. PubMed ID: 27349429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
    Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
    Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic density and breast cancer in women from high risk families.
    Ramón Y Cajal T; Chirivella I; Miranda J; Teule A; Izquierdo Á; Balmaña J; Sánchez-Heras AB; Llort G; Fisas D; Lope V; Hernández-Agudo E; Juan-Fita MJ; Tena I; Robles L; Guillén-Ponce C; Pérez-Segura P; Luque-Molina MS; Hernando-Polo S; Salinas M; Brunet J; Salas-Trejo MD; Barnadas A; Pollán M
    Breast Cancer Res; 2015 Jul; 17(1):93. PubMed ID: 26163143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
    Strickland KC; Howitt BE; Shukla SA; Rodig S; Ritterhouse LL; Liu JF; Garber JE; Chowdhury D; Wu CJ; D'Andrea AD; Matulonis UA; Konstantinopoulos PA
    Oncotarget; 2016 Mar; 7(12):13587-98. PubMed ID: 26871470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origins of breast cancer associated with mammographic density: a testable biological hypothesis.
    Boyd N; Berman H; Zhu J; Martin LJ; Yaffe MJ; Chavez S; Stanisz G; Hislop G; Chiarelli AM; Minkin S; Paterson AD
    Breast Cancer Res; 2018 Mar; 20(1):17. PubMed ID: 29514672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human glandular organoid formation in murine engineering chambers after collagenase digestion and flow cytometry isolation of normal human breast tissue single cells.
    Huo CW; Huang D; Chew GL; Hill P; Vohora A; Ingman WV; Glynn DJ; Godde N; Henderson MA; Thompson EW; Britt KL
    Cell Biol Int; 2016 Nov; 40(11):1212-1223. PubMed ID: 27590622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
    van Zelst JCM; Mus RDM; Woldringh G; Rutten MJCM; Bult P; Vreemann S; de Jong M; Karssemeijer N; Hoogerbrugge N; Mann RM
    Radiology; 2017 Nov; 285(2):376-388. PubMed ID: 28609204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
    Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
    Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue.
    Bergholtz H; Lien TG; Ursin G; Holmen MM; Helland Å; Sørlie T; Haakensen VD
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):163-175. PubMed ID: 30613869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.